You're running a multiplier on what is effectively our preclinical market valuation. Why? Are we selling tomorrow?
I'm sure if CPACS is clinically validated RAC will pursue geographic licensing deals with development milestones (revenue) to closer align our market valuation with the value of our IP.
RAC - Charts & Price Action, page-20709
-
- There are more pages in this discussion • 1,498 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.025(1.49%) |
Mkt cap ! $285.4M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $17.95K | 10.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2240 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 658 | 1 |
View Market Depth
| Last trade - 11.38am 13/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |